GB-115 for Neuroprotection
Research, mechanism, dosing, and effectiveness of GB-115 for neuroprotection.
Quick Answer
GB-115 may protect neurons through NGF-like activity.
Evidence Level
Human Trials
Typical Dose
Under investigation
Results Timeline
Neuroprotective effects in studies
FDA Status
Research Only
How GB-115 Works for Neuroprotection
Nerve growth factor pathway activation.
About Neuroprotection
Protection of brain cells from damage and neurodegenerative processes.
Research Evidence
Clinical studies in patients with Generalized Anxiety Disorder (GAD) showed GB-115 (6mg/day) significantly improved reaction time, attention, and processing speed within 7 days of treatment. A 21-day trial with 31 patients demonstrated anxiolytic effects comparable to benzodiazepines without sedation or dependency. Currently in Phase II/III trials (NCT05586789) for anxiety disorders. Anecdotal reports suggest benefits for ADHD symptoms, though direct ADHD trials are pending.
Dosing for Neuroprotection
Recommended Dose
Under investigation
Frequency
2-3 times daily (morning, afternoon, evening)
Administration
Oral tablets or sublingual
Duration
21+ days in clinical trials, effects noted by day 7
Note: CCK-1 receptor antagonist from Russia. Clinical trial data showed 6 mg/day effective for 21-day cycles with cognitive improvements by day 7. Oral or sublingual administration. No sedation or dependency reported. Some users take 2-4 mg as needed for situational use.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Generally well-tolerated
- •Minimal sedation compared to benzodiazepines
- •Headache (rare)
- •Mild gastrointestinal discomfort
- •No reported dependency or withdrawal
- •Limited long-term safety data
Frequently Asked Questions
Does GB-115 help with neuroprotection?
GB-115 may protect neurons through NGF-like activity.
How does GB-115 work for neuroprotection?
Nerve growth factor pathway activation....
What dose of GB-115 should I use for neuroprotection?
Under investigation
How long until I see results?
Neuroprotective effects in studies
Other Peptides for Neuroprotection
These peptides are also researched for neuroprotection.
Selank
Clinical TrialsA synthetic peptide derived from tuftsin, an immunomodulatory peptide. Approved in Russia for anxiety and nootropic effects. Known for anxiolytic properties without sedation.
Semax
Clinical TrialsA synthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Approved in Russia for stroke and cognitive enhancement. Known for nootropic and neuroprotective effects.
Cerebrolysin
Clinical TrialsA mixture of low-molecular-weight neuropeptides derived from pig brain. Approved in many countries for stroke, traumatic brain injury, and dementia.
Dihexa
PreclinicalA potent cognitive-enhancing peptide derived from angiotensin IV. Reported to be 10 million times more potent than BDNF at promoting synaptogenesis.
Educational Information Only
This information about GB-115 for neuroprotection is for educational purposes only. Always consult with qualified healthcare providers before using any peptide. Individual results may vary.